Flex Pharma Inc Stock price Nasdaq
Equities
US33938A1051
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.56M |
---|---|---|---|---|---|
Net income 2022 | -31M | Net income 2023 | -12M | EV / Sales 2022 | - |
Net cash position 2022 | 12.11M | Net cash position 2023 | 5.61M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.1
x | P/E ratio 2023 |
-0.17
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.55% |
Managers | Title | Age | Since |
---|---|---|---|
David Arthur
CEO | Chief Executive Officer | 61 | 19-07-18 |
Mark Rosenblum
DFI | Director of Finance/CFO | 70 | 19-09-09 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19-07-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Hanish
BRD | Director/Board Member | 76 | 19-07-18 |
Paul Lammers
BRD | Director/Board Member | 66 | 19-07-18 |
Jonathan Lieber
BRD | Director/Board Member | 54 | 20-06-18 |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |